CCT241736, CAS [[1402709-93-6]]
Artikelnummer:
TGM-T4428
- Bilder (1)
| Artikelname: | CCT241736, CAS [[1402709-93-6]] |
| Artikelnummer: | TGM-T4428 |
| Hersteller Artikelnummer: | T4428 |
| Alternativnummer: | TGM-T4428-1MLX10MM(INDMSO),TGM-T4428-2MG,TGM-T4428-5MG,TGM-T4428-10MG,TGM-T4428-25MG,TGM-T4428-50MG,TGM-T4428-100MG |
| Hersteller: | TargetMol |
| Kategorie: | Biochemikalien |
| CCT241736 is an orally bioavailable dual FLT3/Aurora kinase inhibitor that also inhibits clinically relevant FLT3-resistant mutants including FLT3-ITD and FLT3, CCT241736, an advanced analog of CCT137690, is a preclinical development candidate for the treatment of human malignancies, and in particular AML in adults and children. |
| Molekulargewicht: | 456.37 |
| Reinheit: | 96.20% |
| CAS Nummer: | [1402709-93-6] |
| Formel: | C22H23Cl2N7 |
| Target-Kategorie: | FLT|||Aurora Kinase |

